Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry - FDA Guidance Document

Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry - FDA Guidance Document | Global Key Solutions